Thursday, June 1, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor
Director, Leukemia & Lymphoma Program
Co-Director, Developmental Therapeutics Program
Children's Hospital of Wisconsin
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Clinical Assistant Professor of Medicine
Adjunct Clinical Professor of Nursing
Director, Advanced Practice and Clinical Integration
The University of Arizona Cancer Center
Tucson, Arizona, United States
Nurse Practitioner
Princess Máxima Center for Pediatric Oncology
Utrecht, The Netherlands
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)
This educational activity is intended for oncology nurses and nurse practitioners who manage patients with ALL receiving asparaginase-based therapy.
The goal of this activity is for learners to be better able to care for patients with acute lymphoblastic leukemia (ALL) who are receiving asparaginase-based therapies.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor
Director, Leukemia & Lymphoma Program
Co-Director, Developmental Therapeutics Program
Children's Hospital of Wisconsin
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Clinical Assistant Professor of Medicine
Adjunct Clinical Professor of Nursing
Director, Advanced Practice and Clinical Integration
The University of Arizona Cancer Center
Tucson, Arizona, United States
Nurse Practitioner
Princess Máxima Center for Pediatric Oncology
Utrecht, The Netherlands
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CE Released: 4/28/2023
Valid for credit through: 4/28/2024
processing....
Download the pdf.
| « Return to: Sharing Nursing Pearls for Acute Lymphoblastic Leukemia: Enhancing Outcomes With Asparaginase Therapy |
